Enhanced Blood Coagulation and Fibrinolysis in a Patient with Primary Amyloidosis

Summary A case of primary amyloidosis associated with blood coagulation abnormalities is presented. Enhancement of coagulation, suspected because of acceleration of the thromboplastin activation test and of abnormal thrombelastography patterns, was confirmed by the presence of thrombi observed at necropsy. Increased systemic fibrinolysis was evidenced by accelerated clot lysis, increased euglobulin activity, and decreased plasminogen. The presence of fragmented red cells in the peripheral blood smear was consistent with a microangiopathic process. Despite these abnormalities, there were no major changes in levels of coagulation factors. Episodes of massive bleeding occurred when major changes in coagulation or fibrinolysis were absent, supporting the suggestion that vascular infiltration by amyloid is a major cause of hemorrhage.

[1]  A. Todd,et al.  Estimation of Fibrinogen , 1972, Journal of Clinical Pathology.

[2]  T. Astrup,et al.  Serum Effects Following Tissue Thromboplastin Infusion , 1969, Thrombosis and Haemostasis.

[3]  P. Didisheim,et al.  Intravascular coagulation in systemic amyloidosis. , 1969, Thrombosis et diathesis haemorrhagica. Supplementum.

[4]  B. Bull,et al.  Microangiopathic Haemolytic Anaemia: Mechanisms of Red‐Cell Fragmentation: in Vitro Studies , 1968, British journal of haematology.

[5]  E. Deutsch Fibrinolysis. A Standardized Fibrin Plate Method and a Fibrinolytic Assay of Plasminogen , 1968, Thrombosis and Haemostasis.

[6]  E. Mohler,et al.  A group of patients with impaired plasma fibrinolytic system and selective inhibition of tissue activator-induced fibrinolysis. , 2009, Scandinavian journal of haematology.

[7]  T. Astrup,et al.  A Comparative Study of Coagulation and Fibrinolysis in Blood from Normal Men and Women , 1966, British journal of haematology.

[8]  M. Verstraete,et al.  EXCESSIVE CONSUMPTION OF BLOOD COAGULATION COMPONENTS AS CAUSE OF HEMORRHAGIC DIATHESIS. , 1965, The American journal of medicine.

[9]  T. Astrup,et al.  THE ESTIMATION OF FIBRINOGEN. A REVISION. , 1965, Scandinavian journal of clinical and laboratory investigation.

[10]  R. Chakrabarti,et al.  Effect of Corticosteroid Therapy on Fibrinolysis in Patients With Inflamatory and Non-inflammatory Conditions* , 1964, British medical journal.

[11]  T. Astrup,et al.  Estimation of thromboplastin activation in plasma. , 1961, Scandinavian journal of clinical and laboratory investigation.

[12]  S. Niewiarowski,et al.  AN EVALUATION OF THE EUGLOBULIN METHOD FOR THE DETERMINATION OF FIBRINOLYSIS , 1959, Journal of clinical pathology.

[13]  E. Cliffton,et al.  The determination of plasma fibrinogen by turbidity with ammonium sulfate. , 1953, Archives of biochemistry and biophysics.